June 29th, 2011|
June 30, 2011
A new ruling from the US Supreme Court stated that makers of generic drugs are immune from warning the public about side effects that could cause drug injury.
But generic drug makers must be in compliance with federal requirements when making labels that include drug injury risks.
This ruling could promote more risk of drug injury because many insurance companies require patients to use generic drugs whenever possible and some generic drug labels don’t disclose all of the side effects.
According to usatoday.com, 75% of prescriptions drugs in the United states are generics.
Does this decision change your mind about being prescribed generic drugs? Do you think the same laws for brand-name drugs should apply to generic drugs?
Tell the drug injury lawyers at Ferrer, Poirot & Wansbrough Attorneys at Law if you or someone you know has suffered drug injuries.
January 20th, 2011|
January 20, 2011
With the development of new drugs, there is hope for cures or at least treatments for patients coping with chronic illness. However, new drugs may also have risks that don’t immediately present themselves.
Unfortunately, a newer drug is being recalled due to its risk of drug injuries, including liver failure.
According to AFP, Sanofi-Aventis is warning patients of drug injuries for which Dronedarone, a drug used to treat irregular heart rhythms and marketed as Multaq, could increase risks.
Patients who have taken the drug have experienced kidney problems, including two patients who had to have kidney transplants as a result of the drug injuries.
The company plans to change the labels for the medication to reflect the increased risk for drug injuries as soon as possible.
Have you ever suffered a drug injury due to prescription medication? Tell the drug injury lawyers at Ferrer, Poirot & Wansbrough Attorneys at Law about your loss. Let them help you.